big fish casino facebook homepage
What does Big Tech hope to gain from warming up to Trump?Scott Bessent: The Finance Maven Set to Navigate U.S. TreasuryRoivios Initiates Landmark Study to Demonstrate Safety and Efficacy of an Innovative Renal Assist Device for Cardiac Surgery Patients With Kidney Disease NASSAU, Bahamas , Dec. 19, 2024 /PRNewswire/ -- Roivios , a pioneering clinical-stage medical device company dedicated to revolutionizing kidney health, proudly announces that its research and development arm, 3ive Labs, has secured approval for an Investigational Device Exemption (IDE) from the FDA. This approval paves the way for a pivotal trial of the JuxtaFlow Renal Assist Device (RAD), marking a transformative step forward in enhancing outcomes for cardiac surgery patients with renal insufficiency. The GRADIENT ( G roundbreaking R enal A ssist D evice I ntervening to EN hance cardio T horacic surgery outcomes) trial is designed to address the critical need for renal support among cardiac surgery patients undergoing cardiopulmonary bypass (CPB). These patients often face increased risks of postoperative complications, such as worsening renal dysfunction, which can lead to extended ICU stays and increased mortality. "The GRADIENT Trial offers an invaluable opportunity to further explore renal support during cardiac surgery," said Dr. Evelio Rodriguez , a renowned heart surgeon at Ascension Saint Thomas in Nashville, TN , and the National Principal Investigator of the GRADIENT trial. "The JuxtaFlow device offers new hope for some of our most vulnerable patients." JuxtaFlow RAD is an innovative device designed to potentially improve kidney function during times of acute stress. By applying a gentle suction to the kidney's outlet, it aims to enhance blood filtration more efficiently. This groundbreaking approach was recognized with an FDA Breakthrough Device Designation in April. The GRADIENT study will be a prospective, multicenter, randomized, controlled, open-label trial that plans to enroll patients with renal insufficiency (eGFR 15-60 ml/min) undergoing elective or urgent cardiac surgery requiring CPB. The study seeks to evaluate the safety and effectiveness of the JuxtaFlow RAD to sustain or enhance renal function during and following CPB surgery. "Achieving Breakthrough Device Designation was instrumental in securing IDE approval," noted John Erbey , Chief Executive Officer at Roivios. "This initiative is the culmination of a decade of technological and clinical advancements in addressing kidney disease management challenges. Our ongoing dialogue with the FDA is paving the way for more effective management, empowering patients to thrive. We are eager to commence IDE enrollment and explore the JuxtaFlow RAD's potential to improve surgical outcomes and enhance patient quality of life." For more information about Roivios and the JuxtaFlow Renal Assist Device, please visit Roivios.com . About JuxtaFlow RAD The JuxtaFlow RAD is a pioneering investigational device set to transform kidney support therapy. Acknowledging the harmful effects of fluid accumulation and pressure on the kidneys, Roivios has advanced beyond traditional blood filtration methods that can further stress the kidneys. By applying mild, controlled negative pressure within the kidney's collecting system, the device has the potential to maintain and improve filtration and support recovery. This novel approach holds promise for a compelling value proposition by preserving kidney function and expediting patient recovery, ultimately reducing hospital stays and associated costs. Equipped with a proprietary specialized catheters and pump, the device optimizes kidney function during critical recovery periods, such as post-surgery. Currently, the JuxtaFlow RAD is under investigation and is not available for sale in any geography. About Roivios Roivios is a clinical-stage medical device company committed to pioneering solutions for kidney health. Our lead product, the JuxtaFlow Renal Assist Device (RAD), is designed to preserve kidney function and offer a proactive approach to managing kidney disease. We aim to demonstrate improved renal outcomes, potentially reducing the need for dialysis, and lowering healthcare costs. Holding proprietary patents in key kidney technologies, we aim to revolutionize kidney disease management. With plans to extend its application beyond kidney disease to various medical settings, Roivios is preparing for a transformative U.S. launch, aiming to redefine kidney disease management and improve patient quality of life. Discover more at roivios.com . This release contains forward-looking statements subject to risks and uncertainties. Actual results may differ significantly. Media Contact : Kelly Krueger , Krueger PR, kelly@kruegerpr.com View original content to download multimedia: https://www.prnewswire.com/news-releases/fda-grants-ide-approval-for-the-pivotal-trial-of-the-juxtaflow-renal-assist-device-rad-302336698.html SOURCE Roivios, ltd
Gordon Brown declares opposition to assisted dying lawForge Institute Launches Phoenix Xcelerator to Scale Growth of Defense Tech StartupsZefiro Methane Corp. 2024 Year in Review: Accelerating Commercial Growth and Operational Impact
Lebanon is closing all its land border crossings with Syria except for a main one that links Beirut with the Syrian capital Damascus, the General Security Directorate said Friday. The decision came hours after an Israeli airstrike damaged a border crossing in northern Lebanon just days after it was reopened. Separately, Jordan’s interior minister said the Naseeb border crossing with Syria had been closed because of the security situation on the Syrian side. He spoke after Syrian opposition activists said insurgents had captured the main border crossing with Jordan, forcing the Syrian authorities to leave. Separately, Israel’s military said it planned to reinforce its positions in the Israeli-annexed Golan Heights and near the border with Syria. Israel said it was “monitoring developments and is prepared for all scenarios, offensive and defensive alike.” Meanwhile, Syrian insurgents entered the central towns of Rastan and Talbiseh early Friday just north of the central city of Homs, bringing them closer Syria’s third largest city, an opposition war monitor and pro-government media both reported. The breakthrough came a day after jihiadi-led opposition fighters captured the central city of Hama , Syria’s fourth largest. In other developments, a Hamas official said international mediators have resumed negotiations with the Palestinian militant group and Israel over a ceasefire in Gaza, and he was hopeful a deal to end the 14-month war is within reach. Israel's war against Hamas has destroyed vast areas of Gaza and displaced 90% of the population of 2.3 million, often multiple times. The war began when Hamas-led militants stormed into southern Israel in October 2023, killing some 1,200 people, mostly civilians, and taking around 250 people hostage . Israel’s blistering retaliatory offensive has killed at least 44,500 Palestinians , more than half of them women and children, according to Gaza’s Health Ministry, which does not say how many of the dead were combatants. Israel says it has killed over 17,000 militants, without providing evidence. Here's the Latest: CAIRO — Israel said Friday that “thousands of food packages and sacks of flour” were delivered to the isolated northernmost reaches of Gaza, where hunger experts warn famine could be underway. The delivery would mark one of the first successful convoys to the area, which is besieged by Israeli troops that have mounted a fierce offensive in Gaza’s north since early October. COGAT, the Israeli military agency that controls the border crossings into Gaza, said the aid was delivered to the town of Beit Hanoun. Israeli authorities did not publicly say who delivered the aid, and did not provide details on the exact amount of aid involved. COGAT released photos of flatbed trucks driving past rubble, some carrying what appeared to be 25-kilogram (55 pound) sacks of aid and others with cargo covered under tarps. The U.N. has struggled to deliver aid to the area in recent weeks. Alia Zaki, a spokesperson for the World Food Program, told The Associated Press that nearly no food has entered the area for two months, and that the agency’s daily requests to enter the area have been denied by Israel. Of two missions that have been approved since Oct. 6, Zaki said, only two trucks of aid were delivered to a shelter that Israeli soldiers ordered to evacuate soon after and then burned. The situation in northern Gaza has prompted hunger experts to warn that famine is either near or may already be underway. BEIRUT — A Kurdish-led force in Syria that's backed by the United States says it has taken positions along the border with Iraq, replacing Syrian government forces. The move by the Syrian Democratic Forces to capture areas on the west bank of the Euphrates River is likely to cut the land line that links Iran with the Mediterranean coast. The SDF said in a statement that its fighters were deployed in the eastern city of Deir el-Zour and west of the Euphrates for the safety of civilians. “Our primary objective is to protect our security and the security of our people,” it said about the deployment. SDF spokesman Farhad Shami told The Associated Press that their fighters are not in control of the Boukamal border crossing with Iraq. Rami Abdurrahman of the Britain-based Syrian Observatory for Human Rights, an opposition war monitor, said Iran-backed fighters have evacuated the border crossing point of Boukamal and the SDF is expected to control it later. The Boukamal border crossing has been a main supply line for Iran-backed fighters, including Lebanon’s Hezbollah, who had opened the corridor that links Iran with the Mediterranean in 2017. The developments come as jihadi-led insurgents in northwestern Syria have made stunning advances over the past week that have so far met little resistance from government troops. KHAN YOUNIS, Gaza Strip — Crowds of displaced Palestinians, some carrying cooking pots and crying children, gathered at an aid kitchen in the southern Gaza city of Khan Younis on Friday, but many left with nothing. “The food ran out,” said Adel Mohammad, who was hoping to get a meal of rice – the only food being served — for his children. “At night they wake up hungry.” After the kitchen shut down, children used their hands to scoop bits of rice left in large empty cooking pots. The World Food Program has warned that the humanitarian response in Gaza is “nearing collapse as famine looms.” The U.N. agency says Israeli restrictions on aid deliveries, along with the breakdown of law and order in Gaza, has made it difficult for aid convoys to reach displaced Palestinians. Concerns are growing with the onset of another winter of war. Hundreds of thousands of Palestinians, many displaced repeatedly by Israeli attacks, are living in tent camps, reliant on international aid. Experts have already warned of famine in northern Gaza, which Israeli forces have almost completely isolated since early October. BEIRUT -- Lebanon’s General Security Directorate said Friday the country is closing all land border crossing with Syria except for a main one that links Beirut with the Syrian capital Damascus. The decision by the security agency in charge of border crossings came hours after an Israeli airstrike damaged the Arida border crossing with Syria in north Lebanon, days after it was reopened. “Border crossings will be closed until further notice for the safety of travelers,” the agency said in a statement posted on X. It said that the only border crossing that will be kept open is Masnaa in Lebanon’s eastern Bekaa Valley. Lebanon’s state news agency said Friday the airstrike on the Arida crossing caused heavy material damage and cut the road. The Israeli military said fighter jets attacked the border crossing between Lebanon and Syria, adding that they were used to transfer munitions for Lebanon’s Hezbollah group. BEIRUT - Syrian opposition activists say insurgents have captured a main border crossing with Jordan forcing Syrian authorities to leave it. Shortly afterward, Jordan’s Interior Minister al-Frayeh said the Naseeb border crossing with Syria had been closed because of the security situation on the Syrian side. Opposition activists posted videos online showing people storming the border crossing with Jordan, which was in rebel hands until government forces regained control of it in 2018. Ahmad al-Masalmeh, an opposition activist based in France who covers events in southern Syria, told The Associated Press that local gunmen have captured the Naseeb crossing as well as several other areas in the southern province of Daraa where the uprising against President Bashar Assad began in March 2011. Syrian troops have evacuated checkpoints in several areas including the villages of Inkhil, Nawa and Jassem, he added. JERUSALEM — Israel’s military said on Friday that it planned to reinforce its forces stationed in the Golan Heights and near the border with Syria, where civil war has reignited between the government and rebel groups. The Israeli military said in a statement that it was “monitoring developments and is prepared for all scenarios, offensive and defensive alike.” After 13 years of civil war, Syrian insurgents are gaining ground, first taking cities in the country’s north and on Friday entering cities in central Syria. It comes as rebel groups mount new challenges to Russia- and Iran-backed Syrian forces, including in Aleppo, the country’s largest city. Since Oct. 7, 2023, Israel has intermittently struck areas in Syria seen as strongholds of Hezbollah, the Lebanese militant group it is at war with in Lebanon. The advances of the Syrian insurgents adds new instability on Israel’s northern border, two months after it invaded neighboring Lebanon. Israel’s defense minister and military chief of staff met to discuss the situation Thursday. Israeli media reported there is concern in the country’s security establishment that the rebels would advance until they reached the Golan Heights, territory occupied by Israel, gaining control of Syrian weapons stockpiles along the way. Writing in the Israeli daily Yedioth Ahoronoth Friday, veteran military correspondent Ron Ben-Yishai wrote that Israel may “prefer” to destroy the weapons storehouses so they won’t fall into the hands of the rebels. Israel seized control of the Golan Heights from Syria in the 1967 Mideast war. Syria has constantly accused Israel of launching attacks against it from territory it occupies in the Golan Heights. Israel has frequently struck Syria over the years. BEIRUT — Syrian insurgents entered two central towns early Friday just north of the central city of Homs, bringing them closer Syria’s third largest city, an opposition war monitor and pro-government media both reported. The break into Rastan and Talbiseh came a day after opposition gunmen captured the central city of Hama , Syria’s fourth largest, after the Syrian army said it withdrew to avoid fighting inside the city and spare the lives of civilians. The insurgents, led by the jihadi Hayat Tahrir al-Sham group, or HTS, have said that they will march to Homs and Damascus, President Bashar Assad’s seat of power. The city of Homs, parts of which were controlled by insurgents until 2014, is a major intersection point between the capital, Damascus, and Syria’s coastal provinces of Latakia and Tartus where Assad enjoys wide support. Homs province is Syria’s largest in size and borders Lebanon, Iraq and Jordan. Insurgents are now 5 kilometers (3 miles) away from Homs, according to the Britain-based Syrian Observatory for Human Rights, an opposition war monitor. “The battle of Homs is the mother of all battles and will decide who will rule Syria,” said Rami Abdurrahman, the Observatory’s chief. MANAMA, Bahrain — Iran said Friday it conducted a successful space launch, the latest for its program the West alleges improves Tehran’s ballistic missile technology. Iran conducted the launch using its Simorgh program , a satellite-carrying rocket that had had a series of failed launches, at Iran’s Imam Khomeini Spaceport in rural Semnan province. That’s the site of Iran’s civilian space program. The Simorgh carried what Iran described as an “orbital propulsion system,” as well as two research systems to a 400-kilometer (250-mile) orbit above the Earth. A system that could change the orbit of a spacecraft would allow Iran to geo-synchronize the orbits of its satellites. Tehran has long sought that ability. Iran also put the payload of the Simorgh at 300 kilograms (660 pounds), heavier than its previous successful launches. There was no immediate independent confirmation the launch was successful. The U.S. military did not immediately respond to a request for comment. The announcement comes as heightened tensions grip the wider Middle East over Israel’s continued war on Hamas in the Gaza Strip and as an uneasy ceasefire holds in Lebanon. MELBOURNE, Australia — Arsonists extensively damaged a Melbourne synagogue on Friday in what Australia’s prime minister condemned as an antisemitic attack on Australian values. The blaze in the Adass Israel Synagogue is an escalation in targeted attacks in Australia since the war began between Israel and Hamas last year. Cars and buildings have been vandalized and torched around Australia in protests inspired by the war. A witness who had come to the synagogue to pray saw two masked men spreading a liquid accelerant with brooms inside the building at 4:10 a.m., officials said. About 60 firefighters with 17 fire trucks responded to the blaze, which police said caused extensive damage. Investigators have yet to identify a motive, but Prime Minister Anthony Albanese blamed antisemitism. “This was a shocking incident to be unequivocally condemned. There is no place in Australia for an outrage such as this,” Albanese told reporters. “To attack a place of worship is an attack on Australian values. To attack a synagogue is an act of antisemitism, is attacking the right that all Australians should have to practice their faith in peace and security,” he added. ISTANBUL — A Hamas official says international mediators have resumed negotiating with the militant group and Israel over a ceasefire in Gaza, and that he was hopeful a deal to end the 14-month war was within reach. Ceasefire negotiations were halted last month when Qatar suspended talks with mediators from Egypt and the United States because of frustration over a lack of progress between Israel and Hamas. But there has been a “reactivation” of efforts in recent days to end the fighting, release hostages from Gaza and free Palestinian prisoners in Israel, according to Bassem Naim, an official in Hamas’ political bureau who spoke with The Associated Press in Turkey on Thursday. Another official familiar with the talks confirmed the return of Qatari mediators. The official spoke Thursday on condition of anonymity because they were not authorized to discuss the negotiations with the media. Since the talks broke down, there have been significant shifts in the global and regional landscape. Donald Trump won the U.S. presidential election, and a ceasefire was declared last week between Israel and Hamas ally Hezbollah in Lebanon. Trump is a staunch supporter of Israel, but Naim said he believes the incoming administration could “affect the situation positively” given that Trump had made halting wars in the region part of his campaign platform. Trump this week called for the release of all hostages held in Gaza by the time he takes office on Jan. 20, saying there would be “hell to pay” if that doesn’t happen. WASHINGTON -- Three U.S. service members were being evaluated for potential traumatic brain injuries following an attack near a base in eastern Syria this week, Pentagon press secretary Maj. Gen. Pat Ryder said Thursday. Ryder said U.S. Central Command is still evaluating who was behind the attack near Mission Support Site Euphrates, which prompted the U.S. to conduct counter strikes on Tuesday. At the time, the Pentagon said rockets and mortars had landed in the vicinity of the base. The U.S. has about 900 troops in Syria to conduct missions to counter the Islamic Stage group. By Lolita BaldorU.S. stocks rose to records after data suggested the job market remains solid enough to keep the economy going, but not so strong that it raises immediate worries about inflation. The S&P 500 climbed 0.2%, just enough top the all-time high set on Wednesday, as it closed a third straight winning week in what looks to be one of its best years since the 2000 dot-com bust. The Dow Jones Industrial Average dipped 0.3%, while the Nasdaq composite climbed 0.8% to set its own record. Treasury yields eased after the jobs report showed stronger hiring than expected but also an uptick in the unemployment rate. On Friday: The S&P 500 rose 15.16 points, or 0.2%, to 6,090.27. The Dow Jones Industrial Average fell 123.19 points, or 0.3%, to 44,642.52. The Nasdaq composite rose 159.05 points, or 0.8%, to 19,859.77. The Russell 2000 index of smaller companies rose 12.83 points, or 0.5%, to 2,408.99. For the week: The S&P 500 is up 57.89 points, or 1%. The Dow is down 268.13 points, or 0.6%. The Nasdaq is up 641.61 points, or 3.3%. The Russell 2000 is down 25.73 points, or 1.1%. For the year: The S&P 500 is up 1,320.44 points, or 27.7%. The Dow is up 6,952.98 points, or 18.4%. The Nasdaq is up 4,848.42 points, or 32.3%. The Russell 2000 is up 381.92 points, or 18.8%.
Loáisiga guaranteed $5 million in 1-year deal with Yankees as he returns from Tommy John surgeryPrice Over Earnings Overview: L3Harris Technologies
Ariana Grande Donates Christmas Gifts to Manchester Children’s Hospitals
Lafayette Renaissance guard Mathew Gordon passes the ball against Westgate defenders during their Sunkist Shootout game Thursday at St. Thomas More. Facebook Twitter WhatsApp SMS Email Print Copy article link Save A large group of freshmen led by Cayden Lancelin and Shadon Lee have the Westgate High boys basketball team on a hot streak. Lancelin and Lee combined to score 43 points as the Tigers knocked off another young talented local squad, Lafayette Renaissance, in the opening round of the St. Thomas More Sunkist Shootout on Thursday. It was the fourth win in five games since Dec. 20 for the Tigers, who erased a double-digit deficit for the 68-58 victory. Westgate (5-3) beat Iowa, which reached the 2023-24 Division II nonselect state tourney, on its home court last weekend, and blew out Division V select runner-up J.S. Clark by 17 points on Monday. "We've had some really good wins," said Westgate oach Oliver Winston, whose team will face the St. Thomas More/Patterson winner at 6 p.m. Friday in the second round. "It's really important when you're young like that, to get some success against a tough schedule. We've had a couple of games where we got blown out by teams with older guys." Westgate, which has lost to Lafayette High (9-0), Sulphur (11-2) and H.L. Bourgeois, fell behind LRCA 12-2 in the first quarter as coach Brad Boyd's Tigers made their first five field goals. "It was a little bit of youth and me not doing a good job of making sure we're tuned in at the beginning of a game," Winston said of the slow start. "I thought we did a good job once we started making some adjustments and turning up the tempo of the game." LRCA (7-3) was led by Matthew Gordon (17 points, four rebounds, three assists, three steals), Bubba Etienne (14 pts, four rebounds, three steals) and Tavion Gallien (nine points, four assists). There were seven lead changes during the game, which was tied seven times. Antonio Quetel, one of 10 Westgate freshmen, put the Tigers ahead 53-52 with 5:15 remaining. Quetel (seven points, five rebounds, three assists) added a jumper from the baseline a few seconds later after a steal by Lancelin, whose 3-pointer made it 59-56 with 2:13 to go. "Cayden really kept us in the game in the first half offensively," Winston said of the freshman, who made 5 of his first 6 field goals and finished just shy of a triple-double with nine rebounds and eight steals (five assists). "It's good to have a kid who can do that. "In the second half, we had other guys step up and help him. Lee does a good job defensively. He's all over the ball, attacking the rim and making shots. He's an overall scorer." Lee finished with five rebounds and four steals. Freshman forward Chance Archangel (7 pts, 8 rebs) and senior forward Peyton Knatt were able to stay in the game despite foul trouble. The two big-bodies were a force inside. Archangel, who picked up his fourth foul in the third quarter, asserted himself in the lane with two buckets in the closing minutes. "I thought we did a good job of hustling, taking charges and getting steals," Winston said. "Once we sped up the game, it's a little better style for us." Four players fouled out and another nine finished the game with either 3-or-4 fouls. "We're carrying 14 players," Winston said. "We're going to play 12. We'll play 14 if we have to. If you're sitting on the bench, you have to be able to play."Roivios Initiates Landmark Study to Demonstrate Safety and Efficacy of an Innovative Renal Assist Device for Cardiac Surgery Patients With Kidney Disease NASSAU, Bahamas , Dec. 19, 2024 /PRNewswire/ -- Roivios , a pioneering clinical-stage medical device company dedicated to revolutionizing kidney health, proudly announces that its research and development arm, 3ive Labs, has secured approval for an Investigational Device Exemption (IDE) from the FDA. This approval paves the way for a pivotal trial of the JuxtaFlow Renal Assist Device (RAD), marking a transformative step forward in enhancing outcomes for cardiac surgery patients with renal insufficiency. The GRADIENT ( G roundbreaking R enal A ssist D evice I ntervening to EN hance cardio T horacic surgery outcomes) trial is designed to address the critical need for renal support among cardiac surgery patients undergoing cardiopulmonary bypass (CPB). These patients often face increased risks of postoperative complications, such as worsening renal dysfunction, which can lead to extended ICU stays and increased mortality. "The GRADIENT Trial offers an invaluable opportunity to further explore renal support during cardiac surgery," said Dr. Evelio Rodriguez , a renowned heart surgeon at Ascension Saint Thomas in Nashville, TN , and the National Principal Investigator of the GRADIENT trial. "The JuxtaFlow device offers new hope for some of our most vulnerable patients." JuxtaFlow RAD is an innovative device designed to potentially improve kidney function during times of acute stress. By applying a gentle suction to the kidney's outlet, it aims to enhance blood filtration more efficiently. This groundbreaking approach was recognized with an FDA Breakthrough Device Designation in April. The GRADIENT study will be a prospective, multicenter, randomized, controlled, open-label trial that plans to enroll patients with renal insufficiency (eGFR 15-60 ml/min) undergoing elective or urgent cardiac surgery requiring CPB. The study seeks to evaluate the safety and effectiveness of the JuxtaFlow RAD to sustain or enhance renal function during and following CPB surgery. "Achieving Breakthrough Device Designation was instrumental in securing IDE approval," noted John Erbey , Chief Executive Officer at Roivios. "This initiative is the culmination of a decade of technological and clinical advancements in addressing kidney disease management challenges. Our ongoing dialogue with the FDA is paving the way for more effective management, empowering patients to thrive. We are eager to commence IDE enrollment and explore the JuxtaFlow RAD's potential to improve surgical outcomes and enhance patient quality of life." For more information about Roivios and the JuxtaFlow Renal Assist Device, please visit Roivios.com . About JuxtaFlow RAD The JuxtaFlow RAD is a pioneering investigational device set to transform kidney support therapy. Acknowledging the harmful effects of fluid accumulation and pressure on the kidneys, Roivios has advanced beyond traditional blood filtration methods that can further stress the kidneys. By applying mild, controlled negative pressure within the kidney's collecting system, the device has the potential to maintain and improve filtration and support recovery. This novel approach holds promise for a compelling value proposition by preserving kidney function and expediting patient recovery, ultimately reducing hospital stays and associated costs. Equipped with a proprietary specialized catheters and pump, the device optimizes kidney function during critical recovery periods, such as post-surgery. Currently, the JuxtaFlow RAD is under investigation and is not available for sale in any geography. About Roivios Roivios is a clinical-stage medical device company committed to pioneering solutions for kidney health. Our lead product, the JuxtaFlow Renal Assist Device (RAD), is designed to preserve kidney function and offer a proactive approach to managing kidney disease. We aim to demonstrate improved renal outcomes, potentially reducing the need for dialysis, and lowering healthcare costs. Holding proprietary patents in key kidney technologies, we aim to revolutionize kidney disease management. With plans to extend its application beyond kidney disease to various medical settings, Roivios is preparing for a transformative U.S. launch, aiming to redefine kidney disease management and improve patient quality of life. Discover more at roivios.com . This release contains forward-looking statements subject to risks and uncertainties. Actual results may differ significantly. Media Contact : Kelly Krueger , Krueger PR, kelly@kruegerpr.com View original content to download multimedia: https://www.prnewswire.com/news-releases/fda-grants-ide-approval-for-the-pivotal-trial-of-the-juxtaflow-renal-assist-device-rad-302336698.html SOURCE Roivios, ltd27 December 2024 Horoscope: What Is the Zodiac Sign of People Celebrating Birthday Today? Know the Sun Sign, Lucky Colour and Number Prediction